» Articles » PMID: 37822801

Effect of Ramadan Fasting on Blood Glucose Level in Pregnant Women with Gestational and Type 2 Diabetes

Overview
Publisher Dove Medical Press
Specialty Endocrinology
Date 2023 Oct 12
PMID 37822801
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pregnant women with diabetes are strongly advised against Ramadan fasting and have religious exemption, but a large proportion still choose to fast. Unfortunately, there is little information about glycemic control in these patients. This study aims to determine the fasting and postprandial blood glucose levels and to predict the risk factors for hypoglycemia in pregnant women with type 2 diabetes mellitus (DM) and gestational DM (GDM) who fast during Ramadan.

Methods: A prospective cohort research was conducted at a single tertiary hospital between 2021 and 2023 on 70 pregnant women with GDM (n = 53) and type 2 DM (n = 17) in their second and third trimester. Their fasting and postprandial blood glucose levels during Ramadan were compared to those of the previous month, and hypoglycemia was defined as blood glucose levels less than 60 mg/dl. Binary regression was used to predict the risk variables for hypoglycemia.

Results: The GDM and type 2 DM groups were similar in terms of age, parity, number of fasting days, and number of daily fasting hours. Only 26.9% of the women who were permitted to fast were given special instructions for Ramadan fasting. Dietary intervention was more common in the GDM group, whereas insulin and metformin treatment were more common in the type 2 DM group. The fasting glucose level decreased significantly after Ramadan fasting in both groups, from 92.5 (17.4) mg/dl to 90 (17.13) mg/dl (p = 0.033). However, there were a significantly higher number of hypoglycemia events in the type 2 DM group. Further, type 2 DM was identified as a risk factor for hypoglycemia (OR = 6.23; 95% CI = 1.04-37.54; P = 0.046.

Conclusion: The present findings indicate that Ramadan fasting may improve fasting glucose control. In addition, type 2 DM was identified as a risk factor for hypoglycemia.

Citing Articles

Maternal and fetal outcomes in gestational diabetes mellitus: a narrative review of dietary interventions.

Phalle A, Gokhale D Front Glob Womens Health. 2025; 6:1510260.

PMID: 40078500 PMC: 11897047. DOI: 10.3389/fgwh.2025.1510260.


Metabolism and diabetes in Ramadan fasting: Exploring health trends and relationships through systematic literature network analysis.

Baharuddin B, Wijaya A Narra J. 2024; 4(2):e850.

PMID: 39280308 PMC: 11392000. DOI: 10.52225/narra.v4i2.850.

References
1.
Kumar S, Diamond T . Ramadan Fasting and Maternal and Fetal Outcomes in Pregnant Women with Diabetes Mellitus: Literature Review. Front Endocrinol (Lausanne). 2022; 13:900153. PMC: 9263982. DOI: 10.3389/fendo.2022.900153. View

2.
Nor Azlin M, Adam R, Sufian S, Wahab N, Mustafa N, Kamaruddin N . Safety and tolerability of once or twice daily neutral protamine hagedorn insulin in fasting pregnant women with diabetes during Ramadan. J Obstet Gynaecol Res. 2010; 37(2):132-7. DOI: 10.1111/j.1447-0756.2010.01330.x. View

3.
Zhu Y, Zhang C . Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Curr Diab Rep. 2016; 16(1):7. PMC: 6675405. DOI: 10.1007/s11892-015-0699-x. View

4.
Alsaedi S, Altalhi A, Nabrawi M, Aldainy A, Wali R . Prevalence and risk factors of gestational diabetes mellitus among pregnant patients visiting National Guard primary health care centers in Saudi Arabia. Saudi Med J. 2020; 41(2):144-150. PMC: 7841639. DOI: 10.15537/smj.2020.2.24842. View

5.
Safari K, Jamil Piro T, Ahmad H . Perspectives and pregnancy outcomes of maternal Ramadan fasting in the second trimester of pregnancy. BMC Pregnancy Childbirth. 2019; 19(1):128. PMC: 6466666. DOI: 10.1186/s12884-019-2275-x. View